1. Home
  2. IVA vs SNDL Comparison

IVA vs SNDL Comparison

Compare IVA & SNDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVA
  • SNDL
  • Stock Information
  • Founded
  • IVA 2011
  • SNDL 2006
  • Country
  • IVA France
  • SNDL Canada
  • Employees
  • IVA N/A
  • SNDL N/A
  • Industry
  • IVA Biotechnology: Pharmaceutical Preparations
  • SNDL Pharmaceuticals and Biotechnology
  • Sector
  • IVA Health Care
  • SNDL Health Care
  • Exchange
  • IVA Nasdaq
  • SNDL Nasdaq
  • Market Cap
  • IVA 769.0M
  • SNDL 638.2M
  • IPO Year
  • IVA 2020
  • SNDL 2019
  • Fundamental
  • Price
  • IVA $5.61
  • SNDL $2.41
  • Analyst Decision
  • IVA Strong Buy
  • SNDL Strong Buy
  • Analyst Count
  • IVA 6
  • SNDL 1
  • Target Price
  • IVA $15.33
  • SNDL $5.00
  • AVG Volume (30 Days)
  • IVA 74.4K
  • SNDL 3.8M
  • Earning Date
  • IVA 09-26-2025
  • SNDL 11-04-2025
  • Dividend Yield
  • IVA N/A
  • SNDL N/A
  • EPS Growth
  • IVA N/A
  • SNDL N/A
  • EPS
  • IVA N/A
  • SNDL N/A
  • Revenue
  • IVA $14,591,573.00
  • SNDL $692,339,389.00
  • Revenue This Year
  • IVA $80.35
  • SNDL $5.52
  • Revenue Next Year
  • IVA N/A
  • SNDL $4.09
  • P/E Ratio
  • IVA N/A
  • SNDL N/A
  • Revenue Growth
  • IVA N/A
  • SNDL 3.54
  • 52 Week Low
  • IVA $1.53
  • SNDL $1.15
  • 52 Week High
  • IVA $6.50
  • SNDL $2.74
  • Technical
  • Relative Strength Index (RSI)
  • IVA 60.84
  • SNDL 59.57
  • Support Level
  • IVA $5.21
  • SNDL $2.33
  • Resistance Level
  • IVA $5.78
  • SNDL $2.62
  • Average True Range (ATR)
  • IVA 0.38
  • SNDL 0.13
  • MACD
  • IVA -0.02
  • SNDL -0.04
  • Stochastic Oscillator
  • IVA 54.82
  • SNDL 36.54

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

About SNDL SNDL Inc.

SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.

Share on Social Networks: